pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$COOKTraeger, Inc.

$COOK
Salt Lake City, UT, USupdated 5mo ago

Traeger or Träger is a German surname. Notable people with the surname include:Albert Traeger (1830–1912), German politician Alfred Traeger (1895–1980), Australian inventor of the pedal wireless Augustyn Träger (1896–1957), Polish-Austrian soldier during World War I and intelligence officer Carsten Träger (1973–2026), German politician Elinor Meissner Traeger (1906–1983), American composer, pianist, and writer Ernst Träger (1926–2015), German judge Jake Traeger, American soccer player John E.

SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(0)

no pipeline products on record

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Insider activity

source: SEC Form 4
routine RSU / option mechanics (1)
  • Apr 21, 26tax coverHord Michael Joseph · Chief Financial Officer163 sh
🐶 Hiring Signal
No open roles indexed yet — view Traeger, Inc. jobs →

News

  • STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
    The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of upfront discounts, to certain providers
    stat · 3d ago
  • STAT+: Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and more
    President Trump’s nominee to lead the FDA was grilled by senators on hot button topics like China, vaccines, and abortion access
    stat · 10d ago
  • STAT+: FDA approves Ultragenyx gene therapy
    Regeneron wins ultra-rare disease drug approval, a validating win for mRNA research, and more biotech news from The Readout
    stat · 1mo ago
  • Opinion: I’m a neurologist. I’ve delivered ALS diagnoses. Then I received one myself
    “Losing the ability to speak has taught me how quickly society conflates physical dependence with diminished personhood,” writes Dr. Christopher Campos.
    stat · 2mo ago
  • What to know about the parasitic diarrhea outbreak
    Fallout from the end of ACA subsidies, the FDA CBER acting director "on planet Earth," and more health news from Morning Rounds
    stat · 2mo ago
  • Opinion: Why we still don’t know what foods are the source of the cyclospora outbreak
    “You cannot thin a system, defer the tools that would speed it up, and then wonder why the public is left guessing,” writes epidemiologist Katrine Wallace.
    stat · 2mo ago
  • Outbreak of diarrhea-causing parasite grows to more than 1,000 cases
    An outbreak of diarrhea-causing parasite has grown to more than 1,000 cases, making it one of the nation’s largest such outbreaks in years.
    stat · 2mo ago
  • STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more
    Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer
    stat · 3mo ago
  • STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
    Pharma updates from the Pharmalot campus via the Pharmalittle newsletter
    stat · 4mo ago
  • Reigniting Your Curiosity During Fellowship
    Megan M. Dupuis, MD, PhD, discusses how oncology fellows can keep their personal and professional curiosities alive during fellowship.
    onclive · 5mo ago
view all news mentions →
identifiers
ticker
$COOK
SEC CIK
0001857853
country
US
source
sec_tickers
mentioned in
10news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 49m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?